Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Winship Cancer Institute"'
Autor:
Limeng Wan, Bradley C. Carthon, Lauren Yantorni, Omer Kucuk, Katherine Emilie Rhoades Smith, Sarah Caulfield, Jacqueline T. Brown, Greta Russler, Bassel Nazha, Mehmet Asim Bilen, Melvin R. Moore, Yuan Liu, Jennifer Ann LaFollette
Publikováno v:
Oncologist
Background Docetaxel (DOC) and abiraterone (ABI) in the upfront setting have separately improved clinical outcomes for metastatic hormone-sensitive prostate cancer (mHSPC), but there are no studies comparing drug efficacies or the influence of racial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66414daab948cc48ef8c5f4e001fbeb8
https://doi.org/10.1002/onco.13848
https://doi.org/10.1002/onco.13848
Autor:
Jean L. Koff, Jackelyn B. Payne, Andres Chang, Robert A. Bednarczyk, Christopher R. Flowers, Pamela B. Allen, Rafi Ahmed
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:239-243
Introduction Influenza infection causes significant morbidity and mortality in patients with cancer, and annual influenza vaccination for individuals with cancer is recommended. We sought to examine the documentation rate of influenza vaccine adminis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfc0d726dca7ff423d05b2589ab97801
https://doi.org/10.1016/j.clml.2018.12.018
https://doi.org/10.1016/j.clml.2018.12.018
Autor:
Mehmet Asim Bilen, Viraj A. Master, T. Anders Olsen, Dylan J. Martini, Jacqueline T. Brown, Yuan Liu, Subir Goyal, Wayne Harris, Sarah Caulfield, Greta Russler, Bassel Nazha, Omer Kucuk, Benjamin Magod, Jamie M. Goldman, Lauren Yantorni, Bradley C. Carthon, Sean Evans
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background Immune checkpoint inhibitors (ICI) have revolutionized the treatment of metastatic renal cell carcinoma (mRCC). Biomarkers for mRCC patients treated with ICI are limited, and body composition is underutilized in mRCC. We investigated the a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a430157a4cf77f04365dc88d4f5b7953
https://doaj.org/article/c543d2d44b484ffcbc19dade7b171e31
https://doaj.org/article/c543d2d44b484ffcbc19dade7b171e31
Autor:
Bonnie S. Glisson, Sara I. Pai, Anish Suri, Megan Leader, Lori J. Wirth, Mark Haydock, Barbara Burtness, Cristina P. Rodriguez, Nabil F. Saba, Mary Simcox, Steven N. Quayle, Dimitrios Colevas, Francis P. Worden, Saso Cemerski, Douglas Adkins, Lara Dunn, Jason Brown, Kenneth J. Pienta, Ammar Sukari, Christine H. Chung, Julie E. Bauman, Michael K. Gibson
Publikováno v:
Regular and young investigator award abstracts.
Background Immuno-STATsTM are novel, modular fusion proteins designed to selectively activate tumor-antigen-specific CD8+ T cells. Human papillomavirus (HPV) associated cancers serve as a model system to assess the safety and efficacy of the Immuno-S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::351afc29fd5136a74a9f6e411ebc8024
https://doi.org/10.1136/jitc-2020-sitc2020.0354
https://doi.org/10.1136/jitc-2020-sitc2020.0354
Autor:
Subir Goyal, Shreyas S. Joshi, Bradley C. Carthon, Greta Russler, Bassel Nazha, Benjamin Magod, Kenneth Ogan, Jacqueline T. Brown, Jamie M. Goldman, Sarah Caulfield, Sean Evans, Yuan Liu, T. Anders Olsen, Julie M. Shabto, Deepak Ravindranathan, Haydn T. Kissick, Omer Kucuk, Viraj A. Master, Mehmet Asim Bilen, Lauren Yantorni, Dylan J. Martini, Wayne Harris
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background Several immune checkpoint inhibitors (ICI) have been approved for the treatment of advanced urothelial carcinoma (UC). There are limited predictive biomarkers for UC patients treated with ICI. In this study, we investigated the association
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::750ff6291fc1d19e03fa78fd61d81135
https://doi.org/10.1136/jitc-2020-sitc2020.0045
https://doi.org/10.1136/jitc-2020-sitc2020.0045
Publikováno v:
Dose-Response, Vol 18 (2020)
Dose-Response
Dose-Response
The primum non nocere letter by Boon et al. urged caution and careful examination of the evidence and logistics of low-dose radiotherapy in COVID-19 patients. This is exactly what was requested in March and what has occurred since late April 2020 whe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f6b1146a5479db27244a764c34dbf45
https://pubmed.ncbi.nlm.nih.gov/32868978
https://pubmed.ncbi.nlm.nih.gov/32868978
Autor:
Pamela B. Allen, Erica Shantha Tarabadkar, A. Mccook, Jeffrey M. Switchenko, Shaunak Varma, Mary Jo Lechowicz
Publikováno v:
Blood. 138:1378-1378
Introduction: Advanced stage mycosis fungoides (MF) has a median survival of 3-5 years, while early stage MF is a chronic disease typically associated with an excellent prognosis and a median survival of 20 years or more. Prior studies suggest approx
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17f12184063d060be040c24547ee2788
https://doi.org/10.1182/blood-2021-146590
https://doi.org/10.1182/blood-2021-146590
Autor:
Reena Lynam, Barbara Burtness, Francis P. Worden, Lara Dunn, Steven Margossian, Ammar Sukari, Bonnie S. Glisson, Tanguy Y. Seiwert, Steve Quayle, Sara I. Pai, Cristina P. Rodriguez, A. Dimitrios Colevas, Matteo Levisetti, Julie E. Bauman, Lori J. Wirth, Nabil F. Saba, Kenneth J. Pienta, Michael K. Gibson, Christine H. Chung, Raymond Moniz, Laura Agensky, Douglas Adkins
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundImmuno-STATsTM are novel, modular fusion proteins designed to selectively activate tumor-antigen-specific CD8+ T cells. CUE-101 is comprised of a human leukocyte antigen (HLA) complex, HLA-A*0201, a peptide epitope derived from the HPV16 E7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb27bf4864aae4a5651efd659528a797
https://doi.org/10.1136/jitc-2021-sitc2021.438
https://doi.org/10.1136/jitc-2021-sitc2021.438
Autor:
Sarah DiGiulio
Publikováno v:
Oncology Times. 43:42-42
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b9770751f81d2da9721c8e2002c36f2
https://doi.org/10.1097/01.cot.0000789392.61687.2a
https://doi.org/10.1097/01.cot.0000789392.61687.2a
Publikováno v:
Oncotarget
// Terry Fei Fan Ng 1, 2, 3, 5 , Jennifer A. Dill 3 , Alvin C. Camus 3 , Eric Delwart 1, 2, * and Erwin G. Van Meir 4, * 1 Blood Systems Research Institute, San Francisco, California, USA 2 Department of Laboratory Medicine, University of California
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e3b630dc6778e1c2402aa59b5add64f
https://doi.org/10.18632/oncotarget.22400
https://doi.org/10.18632/oncotarget.22400